Pavla Kubíčková

Pavla Kubíčková

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
DNDaria Elżbieta Nawrot
Daria Elżbieta Nawrot
GBGhada Bouz
Ghada Bouz
OJOndrej Jandourek
Ondrej Jandourek
KKKlára Konečná
Klára Konečná
PPPavla Paterova
Pavla Paterova
Jan ZitkoJan Zitko
Jan Zitko
Tuberculosis is the number one killer of infectious diseases caused by a single microbe, namely Mycobacterium tuberculosis (Mtb). The success rate of curing this infection is decreasing due to emerging antimicrobial resistance. Therefore, novel treatments are urgently needed. As an attempt to develop new antituberculars effective against both drugs-sensitive and drug-resistant Mtb, we report the synthesis of a novel series inspired by combining fragments from the first-line agents isoniazid and pyrazinamide (series I) and isoniazid with the second-line agent 4-aminosalicylic acid (series II). We identified compound 10c from series II with selective, potent in vitro antimycobacterial activity against both drug-sensitive and drug-resistant Mtb H37Rv strains with no in vitro or in vivo cytotoxicity. In the murine model of tuberculosis, compound 10c caused a statistically significant decrease in colony-forming units (CFU) in spleen. Despite having a 4-aminosalicylic acid fragment in its structure, biochemical studies showed that compound 10c does not directly affect the folate pathway but rather methionine metabolism. In silico simulations indicated the possibility of binding to mycobacterial methionine-tRNA synthetase. Metabolic study in human liver microsomes revealed that compound 10c does not have any known toxic metabolites and has a half-life of 630 min, overcoming the main drawbacks of isoniazid (toxic metabolites) and 4-aminosalicylic acid (short half-life).

15 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MCMartin Chmel
Martin Chmel
OBOldřich Bartoš
Oldřich Bartoš
HKHana Kabíčková
Hana Kabíčková
PPPetr Pajer
Petr Pajer
PKPavla Kubíčková
Pavla Kubíčková
JDJiri DRESLER
Jiri DRESLER
Herein, we present our findings of an early appearance of the Monkeypox virus in Prague, Czech Republic. A retrospective analysis of biological samples, carried out on the 28th of April, revealed a previously unrecognized case of Monkeypox virus (MPxV) infection. Subsequent data analysis confirmed that the virus strain belongs to the ongoing outbreak. Combined with clinical and epidemiological investigations, we extended the roots of the current outbreak at least back to 16th of April, 2022.

14 January 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
JTJiri Trousil
Jiri Trousil
LFLucia Frgelecová
Lucia Frgelecová
PKPavla Kubíčková
Pavla Kubíčková
KŘKristína Řeháková
Kristína Řeháková
VDVladimír Drašar
Vladimír Drašar
OPOto Pavliš
Oto Pavliš
Legionnaires’ disease is a severe form of lung infection caused by bacteria belonging to the genus Legionella. The disease severity depends on both host immunity and L. pneumophila virulence. The objective of this study was to describe the pathological spectrum of acute pneumonia caused by a virulent clinical isolate of L. pneumophila serogroup 1, sequence type 62. In A/JOlaHsd mice, we compared two infectious doses, namely, 104 and 106 CFU, and their impact on the mouse status, bacterial clearance, lung pathology, and blood count parameters was studied. Acute pneumonia resembling Legionnaires’ disease has been described in detail.

21 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
PPPernica Pernica
Pernica Pernica
ZSZoltán Szabó
Zoltán Szabó
MČMartin Čáp
Martin Čáp
OPOto Pavliš
Oto Pavliš
PKPavla Kubíčková
Pavla Kubíčková
Pavel FialaPavel Fiala
Pavel Fiala
In this paper, the authors describe an electromagnetic–hydrodynamic (EMHD) model of the airborne microbiological agent detection concept for the design of a sensor to identify the presence of airborne bacteria and viruses. Based on the model and a laboratory test, a methodology was proposed for the capture and subsequent detection of low-concentration bacterial and viral agents in airborne aerosols. A physical–biological approach was proposed to detect microorganisms based on their physical properties. The principle was validated in the laboratory on samples of defined concentrated water aerosols of Bacillus subtilis (BS) and feline infectious peritonitis virus (FIVP). Repeated tests with different concentrations were performed in the laboratory conditions.